Welcome to our dedicated page for Ecolab SEC filings (Ticker: ECL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Ecolab Inc. (ECL) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Ecolab is a Delaware corporation with common stock listed on the New York Stock Exchange under the symbol ECL, and it uses SEC filings to report earnings, capital markets activity, governance changes and other material events.
Among the most frequently referenced documents are Form 8‑K current reports. Ecolab files 8‑Ks to announce quarterly earnings results, attaching news releases and supplemental data that describe performance across segments such as Global Water, Global Institutional & Specialty, Global Pest Elimination and Global Life Sciences. Other 8‑Ks disclose events like the issuance of debt securities, including notes issued under the company’s shelf registration statement, and board appointments or committee assignments.
Users can also review filings related to Ecolab’s debt and listing status. For example, a Form 25 filing by the New York Stock Exchange documents the removal from listing of certain Ecolab notes, while the company’s common stock remains listed under ECL. These filings outline the terms of specific securities and the rules relied upon for delisting particular debt instruments.
On Stock Titan, Ecolab’s filings are updated as they appear on EDGAR, and AI-powered tools can help summarize lengthy documents so that readers can quickly understand key points, such as segment commentary in earnings releases, the purpose of new notes offerings, or the significance of board and governance disclosures. Investors interested in ECL can use this page to locate 8‑K earnings reports, registration-related documents, and other filings that shape the company’s regulatory and capital markets profile.
Ecolab Inc. reported insider share activity by a company director on 12/31/2025. The director acquired 128 shares of common stock at a price of $263.675 per share and another 128 shares at a price of $0, reflecting stock received through a company plan rather than a market purchase. Following these transactions, the director beneficially owned a total of 9,101.24 shares of Ecolab common stock. The filing notes that this ownership figure includes 20.36 shares acquired through the dividend reinvestment feature of the Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan.
Ecolab Inc. director Judson Althoff reported acquiring 128 shares of Ecolab common stock on 12/31/2025. The shares were acquired at a reported price of $0, indicating they were likely granted as part of a compensation or deferred compensation arrangement rather than purchased on the open market. Following this transaction, Althoff beneficially owned a total of 999.82 shares of Ecolab common stock. This total includes 1.77 shares acquired through a dividend reinvestment feature of the Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan.
Ecolab Inc. director David W. MacLennan reported an open-market purchase of 750 shares of Ecolab common stock. The transaction took place on 12/08/2025 at a price of $257.597 per share, as shown in the Form 4 filing. Following this purchase, he beneficially owns 23,035.08 shares directly. He also has indirect ownership of 3,500 shares through the Kathleen F. MacLennan Revocable Trust and 709 shares through sibling's trusts. The filing is signed by an attorney-in-fact on his behalf, confirming the director-level insider ownership update.
Ecolab Inc. Chairman & CEO Christophe Beck, who is also a director, reported equity holdings and a new stock option grant. As of the reported transactions, he directly beneficially owns 72,644.362 shares of Ecolab common stock and indirectly holds 1,680.35 units in the Ecolab Stock Fund of the Ecolab Savings Plan, equivalent to approximately 3,083 shares as of November 30, 2025.
On December 3, 2025, Beck received an employee stock option covering 64,954 shares of Ecolab common stock at an exercise price of $268.515 per share. The option becomes exercisable in stages: one-third of the option shares on each of the first and second anniversaries of the grant date and the remaining shares on the third anniversary, with the first exercisable date listed as December 3, 2026.
Ecolab Inc. reported an insider equity award for senior vice president and corporate controller Jennifer J. Bradway. On 12/03/2025, she received an employee stock option grant for 4,060 options to buy Ecolab common stock at an exercise price of $268.515 per share. The option becomes exercisable in stages, with one-third of the shares vesting on each of the first and second anniversaries of the grant date and the remaining shares vesting on the third anniversary; 12/03/2026 is listed as the first exercisable date. Following the reported transactions, she beneficially owns 4,357.812 shares of Ecolab common stock directly, which includes 31.862 shares from automatic dividend reinvestment.
Ecolab Inc. reported a stock option grant to an executive officer. Alexandra M. A. Hlila, EVP & GM – Global Pest, received an employee stock option to buy 4,330 shares of Ecolab common stock at an exercise price of $268.515 per share on 12/03/2025. The option becomes exercisable in stages: one-third of the option shares on each of the first and second anniversaries of the grant date and the remaining shares on the third anniversary, with the first tranche becoming exercisable on 12/03/2026. Following this grant, she beneficially owns 4,330 derivative securities (stock options) and holds 85.216 shares of Ecolab common stock directly.
Ecolab Inc. (ECL) reported an insider equity award for an executive. EVP & President – Global Markets Alexander A. De Boo received an employee stock option to buy 4,872 shares of Ecolab common stock at an exercise price of $268.515 per share, granted on 12/03/2025. The option becomes exercisable in stages: one-third of the shares on each of the first and second anniversaries of the grant date, and the remaining shares on the third anniversary, with the first exercisable date shown as 12/03/2026. The option expires on 12/03/2035. Following this grant, the executive reports 5,725.604 shares of Ecolab common stock held directly, along with the new option position of 4,872 derivative securities.
Ecolab Inc. executive Benjamin M. Clark, EVP - Global Supply Chain, reported new equity compensation and updated share holdings. On December 3, 2025, he received an employee stock option to buy 4,872 shares of Ecolab common stock at an exercise price of $268.515 per share. The option becomes exercisable on a cumulative basis: one‑third of the shares on each of the first and second anniversaries of the grant date, and the remaining shares on the third anniversary, with the first exercisable date listed as December 3, 2026 and an expiration date of December 3, 2035.
The filing also notes that Clark’s end-of-period holdings include 2 additional shares acquired through dividend reinvestment on August 11, 2025, and shows 82.581 shares of Ecolab common stock held directly.
Ecolab Inc. reported an equity compensation update for executive vice president of corporate strategy and business development Harpreet Saluja. On 12/03/2025, the executive received an employee stock option grant for 5,954 shares of common stock at an exercise price of $268.515 per share, which becomes exercisable in three annual installments starting 12/03/2026 and ending 12/03/2035.
On 12/04/2025, the first tranche of a prior grant of 3,993 restricted stock units from December 2024 vested, converting 1,331 units into common stock on a one-for-one basis. To cover minimum statutory tax obligations, 407.286 shares were withheld at a price of $263.385 per share, leaving 923.714 shares of common stock directly owned after the transaction.
Ecolab Inc. executive stock option grant disclosed
Ecolab Inc. reported that an executive officer, serving as EVP, General Counsel and Secretary, received a new employee stock option award on December 3, 2025. The option gives the right to buy 5,954 shares of Ecolab common stock at an exercise price of $268.515 per share.
The option is structured to vest in stages. It becomes exercisable, on a cumulative basis, as to one-third of the option shares on each of the first and second anniversaries of the grant date, and the remaining shares vest on the third anniversary. The option is first exercisable on December 3, 2026 and expires on December 3, 2035.